Chongqing Xuanbo Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chongqing Xuanbo Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VOPOTEK. The owner is based in Chongqing.

Rm. 1202, Bldg. 5-2, No. 19, Yuyun Rd.

Chenjiaba St. , Wanzhou Dist.

Chongqing 404028 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VOPOTEK
VOPOTEK
Registered 2021

Trademark Classifications

Chongqing Xuanbo Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Chongqing Xuanbo Technology Co., Ltd. have?

Chongqing Xuanbo Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chongqing Xuanbo Technology Co., Ltd. file in?

Chongqing Xuanbo Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Chongqing Xuanbo Technology Co., Ltd.'s most well-known trademarks?

Chongqing Xuanbo Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as VOPOTEK. These are among 1 currently registered trademark in the portfolio.

What is Chongqing Xuanbo Technology Co., Ltd.'s trademark registration success rate?

Chongqing Xuanbo Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.